Hepatitis A virus cellular receptor 2 (HAVCR2 or TIM-3) is intensely present on NK cells in AML subjects, associated with augmented cytotoxic activity and a better prognosis [41]. This evidence concerns the gene HAVCR2 and acute myeloid leukemia.